DocDollars

Ipsen Innovation

France · Reporting entity ID 100000010514

Total reported 2019–2025
$19.9M
#317 of 2,960 reporting companies — 0% of all reported industry payments
$1.51M in general payments across 683 records, plus $18.4M in research funding across 12,879 records.

How it breaks down

General payments $1,511,972
Research funding $18,373,380

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ipsen Innovation reported $19.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #317 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 683 general payment records and 12,879 research records were filed.

Common questions about Ipsen Innovation

How much has Ipsen Innovation paid US doctors?

Ipsen Innovation reported $19,885,352 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,511,972 in general payments, $18,373,380 in research funding.

How does Ipsen Innovation rank among drug and device companies?

It ranks #317 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ipsen Innovation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.